NCT06200480

Brief Summary

This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. The study will clarify whether the implementation (compliance) and overall satisfaction of the patient are better with follow-up by a headache nurse compared to standard follow-up. Patients with signed written consent will be randomised to either group a: Telephone calls from nurse after two and 6 week or B. Patient-initiated follow-up by their general practitioner.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
147

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2026

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

2.8 years

First QC Date

December 14, 2023

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compliance

    number of participants who have carried out the prescribed preventive treatment, as in minimum duration of two months after the initial visit

    2 months

Secondary Outcomes (2)

  • Number of days to at least a 30% reduction

    3 months

  • Responders

    3 months

Study Arms (2)

Telephone by nurse

ACTIVE COMPARATOR

The headache patients will be contacted by nurse by phone after approximately 2 week and 6 week after start of preventive medical treatment. The patient will have a follow-up visit by neurologist after 3 months.

Other: Telephone by nurse

Patient-initiated follow-up

NO INTERVENTION

The headache patient contact their general practitioner (GP) and/or the neurologist by a study-specific email if they have questions regarding the preventive medical treatment

Interventions

Patient-initiated follow-up at week 2 and 6

Telephone by nurse

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua
  • Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness.

You may not qualify if:

  • Uncertain headache diagnosis.
  • Need further investigation after the initial consultation.
  • Lack of understanding of information provided in Norwegian, both verbally and in writing.
  • Inability to keep a digital headache diary.
  • Need treatment of other comorbid conditions requiring follow-up in specialized healthcare.
  • Treatment with Onabotulinumtoxin A or Calcitonin-gene-related Peptide (CGRP) inhibitors given with three months intervals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Olavs Hospital HF

Trondheim, 7489, Norway

Location

Related Links

MeSH Terms

Conditions

Migraine DisordersCluster Headache

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrigeminal Autonomic Cephalalgias

Study Officials

  • Geir Braathen

    St. Olavs Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Open-label randomized prospetive study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2023

First Posted

January 11, 2024

Study Start

April 21, 2023

Primary Completion

January 21, 2026

Study Completion

January 31, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Publication by home page of NorHead

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
In the near future
Access Criteria
https://www.ntnu.no/norhead/om
More information

Available IPD Datasets

Study Protocol (NorHead)Access
Statistical Analysis Plan (NorHead)Access

Locations